Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease.
Fifty children who had symptomatic sickle cell disease received matched sibling marrow allografts between September 1991 and March 1999, with Kaplan-Meier probabilities of survival and event-free survival of 94% and 84%, respectively. Twenty-six patients (16 male, 10 female) had at least 2 years of follow-up after transplantation and were evaluated for late effects of transplantation and for its impact on sickle cell-related central nervous system (CNS) and pulmonary disease. Patients ranged between 3.3 and 14.0 (median, 9. 4) years of age and had a median follow-up of 57.9 (range 38-95) months after transplantation. Among 22 of 26 patients who had stable donor engraftment, complications related to sickle cell disease resolved, and none experienced further episodes of pain, stroke, or acute chest syndrome. All 10 engrafted patients with a prior history of stroke had stable or improved cerebral magnetic resonance imaging results. Pulmonary function tests were stable in 22 of the 26 patients, worse in two, and not studied in two. Seven of eight patients transplanted for recurrent acute chest syndrome had stable pulmonary function. Linear growth measured by median height standard deviation score improved from -0.7 before transplantation to -0.2 after transplantation. An adverse effect of busulfan conditioning on ovarian function was demonstrated in five of seven evaluable females who are currently at least 13 years of age. None of the four males tested had elevated serum gonadotropin levels. These data confirm that allogenic bone marrow transplantation establishes normal erythropoiesis and is associated with improved growth and stable CNS imaging and pulmonary function in most patients. (Blood. 2000;95:1918-1924)
Walters
M C
MC
Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Storb
R
R
Patience
M
M
Leisenring
W
W
Taylor
T
T
Sanders
J E
JE
Buchanan
G E
GE
Rogers
Z R
ZR
Dinndorf
P
P
Davies
S C
SC
Roberts
I A
IA
Dickerhoff
R
R
Yeager
A M
AM
Hsu
L
L
Kurtzberg
J
J
Ohene-Frempong
K
K
Bunin
N
N
Bernaudin
F
F
Wong
W Y
WY
Scott
J P
JP
Margolis
D
D
Vichinsky
E
E
Wall
D A
DA
Wayne
A S
AS
Pegelow
C
C
Redding-Lallinger
R
R
Wiley
J
J
Klemperer
M
M
Mentzer
W C
WC
Smith
F O
FO
Sullivan
K M
KM
D000293:Adolescent; D000755:Anemia, Sickle Cell / Q000150:complications / Q000401:mortality / Q000628:therapy*; D001827:Body Height; D016026:Bone Marrow Transplantation; D002318:Cardiovascular Diseases / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D018572:Disease-Free Survival; D004702:Endocrine Glands / Q000378:metabolism; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008168:Lung / Q000502:physiology; D008297:Male; D013997:Time Factors; D014019:Tissue Donors